Bank of New York Mellon’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-658
| Closed | -$2.38K | – | 4486 |
|
|
2023
Q1 | $2.38K | Hold |
658
| – | – | ﹤0.01% | 4379 |
|
|
2022
Q4 | $21.2K | Hold |
658
| – | – | ﹤0.01% | 4346 |
|
|
2022
Q3 | $27K | Hold |
658
| – | – | ﹤0.01% | 4409 |
|
|
2022
Q2 | $28K | Sell |
658
-3,894
| -86% | -$166K | ﹤0.01% | 4456 |
|
|
2022
Q1 | $309K | Sell |
4,552
-83
| -2% | -$5.63K | ﹤0.01% | 3998 |
|
|
2021
Q4 | $563K | Buy |
4,635
+85
| +2% | +$10.3K | ﹤0.01% | 3732 |
|
|
2021
Q3 | $640K | Buy |
4,550
+766
| +20% | +$108K | ﹤0.01% | 3657 |
|
|
2021
Q2 | $1.04M | Buy |
3,784
+1,011
| +36% | +$278K | ﹤0.01% | 3390 |
|
|
2021
Q1 | $594K | Sell |
2,773
-149
| -5% | -$31.9K | ﹤0.01% | 3594 |
|
|
2020
Q4 | $707K | Buy |
2,922
+1,243
| +74% | +$301K | ﹤0.01% | 3448 |
|
|
2020
Q3 | $177K | Buy |
1,679
+86
| +5% | +$9.07K | ﹤0.01% | 3872 |
|
|
2020
Q2 | $156K | Sell |
1,593
-474
| -23% | -$46.4K | ﹤0.01% | 3852 |
|
|
2020
Q1 | $156K | Hold |
2,067
| – | – | ﹤0.01% | 3795 |
|
|
2019
Q4 | $168K | Hold |
2,067
| – | – | ﹤0.01% | 3947 |
|
|
2019
Q3 | $252K | Sell |
2,067
-113
| -5% | -$13.8K | ﹤0.01% | 3834 |
|
|
2019
Q2 | $392K | Buy |
2,180
+583
| +37% | +$105K | ﹤0.01% | 3711 |
|
|
2019
Q1 | $255K | Sell |
1,597
-247
| -13% | -$39.4K | ﹤0.01% | 3791 |
|
|
2018
Q4 | $480K | Buy |
1,844
+1,099
| +148% | +$286K | ﹤0.01% | 3506 |
|
|
2018
Q3 | $181K | Buy |
745
+49
| +7% | +$11.9K | ﹤0.01% | 3948 |
|
|
2018
Q2 | $165K | Buy |
+696
| New | +$165K | ﹤0.01% | 3934 |
|